This meeting is provided by the American Association of Heart Failure Nurses (AAHFN). The American Association of Heart Failure Nurses (AAHFN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.
Learning Outcome/Purpose
The Advanced Heart Failure Symposium seeks to improve the understanding and practice of nurses and nurse practitioners by providing lectures, discussion, case studies incorporating the most recent innovations and management strategies in the care of advanced heart failure (HF) patients. The learner will develop an understanding of when to refer this patient population for advanced heart failure therapies as well as other considerations such as utilization of biomarkers, hemodynamic monitoring, right heart failure, treatment of cardiogenic shock, long-term device options and HF management without advanced HF therapies. They will also look for and diagnose cardiac amyloidosis earlier and refer for therapy.
Attendees may earn (up to) *13 contact hours by attending this activity and completing the evaluation.
Attendees can earn one nursing contact hour for every hour of educational time. Learners must complete an evaluation to receive contact hours. The evaluation is available after the activity.
Disclosure/Conflicts of Interest
The planners and faculty for this activity do not have any relevant relationships to disclose, unless listed below. Any resulting conflicts of interest have been resolved according to ANCC guidance:
Dr. Johanna Fajardo disclosed:
1.) Alnylam: Nursing Advisory Board
2.) Eidos: Nursing Advisory Board
3.) Pfizer: Nursing Advisory Board
Dr. Lee Goldberg disclosed:
1.) Respircardia: Consulting fees and research grants
2.) Abbott: Consulting fees
Dr. Keyur Shah disclosed:
1.) Syncardia: Medical Advisory Board and a Consultant
Disclosure of Commercial Support
AAHFN received commercial support from the following organizations:
Alnylam
Pfizer